Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis

QR Code

Informing policy for the Australian context - Costs, outcomes and cost savings of prenatal carrier screening for cystic fibrosis

Bibliographic Details
Main Authors:	Maxwell, Susannah, Brameld, Kate, Youngs, L., Geelhoed, E., O'Leary, Peter
Format:	Journal Article
Published:	Blackwell Publishing 2010
Online Access:	http://hdl.handle.net/20.500.11937/42632

Similar Items

Perceptions of Population Cystic Fibrosis Prenatal and Preconception Carrier Screening Among Individuals with Cystic Fibrosis and Their Family Members
by: Maxwell, Susannah, et al.
Published: (2011)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

Prenatal screening for Down Syndrome in Australia: costs and benefits of current and novel screening strategies
by: O'Leary, Peter, et al.
Published: (2013)

Cost Effectiveness of Screening Individuals With Cystic Fibrosis for Colorectal Cancer
by: Gini, A., et al.
Published: (2018)

Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing
by: Maxwell, S., et al.
Published: (2017)

Human Genetics Society of Australasia Position Statement: Population-Based Carrier Screening for Cystic Fibrosis
by: Delatycki, M., et al.
Published: (2014)

First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21
by: Maxwell, Susannah, et al.
Published: (2016)

Diagnosing Fetal Aneuploidy in Australia: The Impact of Prenatal Screening and the Integration of New Technology
by: Maxwell, Susannah
Published: (2017)

Understanding the Costs of Care for Cystic Fibrosis: an Analysis by Age and Health State
by: Van Gool, K., et al.
Published: (2013)

Newborn bloodspot screening policy framework for Australia
by: O'Leary, P., et al.
Published: (2015)

Impact of prenatal screening and diagnostic testing on trends in Down syndrome births and terminations in Western Australia 1980 to 2013
by: Maxwell, S., et al.
Published: (2015)

Women's understanding and attitudes towards Down syndrome and other genetic conditions in the context of prenatal screening
by: Long, S., et al.
Published: (2017)

Newborn bloodspot screening: setting the Australian national policy agenda
by: Maxwell, Susannah, et al.
Published: (2014)

Public funding for non-invasive prenatal testing for fetal aneuploidy – It's time
by: Maxwell, S., et al.
Published: (2018)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
by: Floto, R. Andres, et al.
Published: (2016)

Airway infection and Pseudomonas aeruginosa in bronchiectasis (cystic fibrosis and non-cystic fibrosis bronchiectasis)
by: Webb, Karmel
Published: (2022)

Paternal experiences of their children’s diagnosis of Cystic Fibrosis following newborn screening diagnosis
by: Priddis, Lynn, et al.
Published: (2010)

The impact of single gene and chromosomal disorders on hospital admissions in an adult population
by: Dye, Danielle, et al.
Published: (2011)

Multiple-breath washout as a lung function test in cystic fibrosis: A cystic fibrosis foundation workshop report
by: Subbarao, P., et al.
Published: (2015)

Cost-savings to medicare from pre-medicare colorectal cancer screening
by: Goede, S., et al.
Published: (2015)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Cystic fibrosis microbiology: advances in antimicrobial therapy
by: Waters, Valerie, et al.
Published: (2015)

Prophylactic anti-staphylococcal antibiotics for cystic fibrosis
by: Smyth, Alan R., et al.
Published: (2014)

Use of a primary epithelial cell screening tool to investigate phage therapy in cystic fibrosis
by: Trend, S., et al.
Published: (2018)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
by: Cenin, Dayna, et al.
Published: (2018)

FRACTURE LIAISON SERVICE REDUCES RE-FRACTURE RATE, COST-EFFECTIVE AND COST SAVING IN WESTERN AUSTRALIA
by: Inderjeeth, C., et al.
Published: (2016)

Compliance with professional guidelines with reference to familial cancer services
by: Kyne, G., et al.
Published: (2011)

Cascade screening based on genetic testing is cost-effective: Evidence for the implementation of models of care for familial hypercholesterolemia
by: Ademi, Z., et al.
Published: (2014)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

METABOLOMIC RESPONSE OF HEALTHY AND CYSTIC FIBROSIS EPITHELIUM TO RHINOVIRUS
by: Agudelo-Romero, P., et al.
Published: (2019)

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)

POLYMICROBIAL INFECTION AND NEUTROPHILIC DISEASE IN CYSTIC FIBROSIS AIRWAYS
by: Laucirica, D.R., et al.
Published: (2019)

Respiratory viral infections in Western Australians with cystic fibrosis
by: Brestovac, Brian, et al.
Published: (2020)

Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis
by: Hurley, M., et al.
Published: (2015)

Prenatal screening of down syndrome.
by: Rosli, Rozita, et al.
Published: (2006)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

Multiple-breath washout outcomes are sensitive to inflammation and infection in children with cystic fibrosis
by: Ramsey, K., et al.
Published: (2017)

The Rise of Low-Cost Carriers in Thailand
by: Sheriff, Thomas
Published: (2008)

Optimising Fibre optics To Save Cost
by: New Straits Times,
Published: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r3s930pd6b1f01261l522l4tig